Marcy Rogers, M.Ed. is back and SpineMark Corporation is alive.
SpineMark and Rogers Live, Announce Partnership
1 min read Premium comments
It was announced on August 15, 2012 that SpineMark and Rogers have formed a partnership with PhDx Systems, Inc. a clinical data outcomes solution, and Millenium Environmental, a company which specializes in management system standardization.
The partnership has, according to a press release, developed an ISO-type spine protocol that will “implement a standardized model for spine care that measures outcomes, quality, patient thru-put, cost of care, administration and operation to insure best care practices, efficacy and accountability.” Called the Spine Protocol Management System, the idea is to allow hospitals to track outcomes, reduce cost and document quality for the services that are provided. Specifically, PhDx has also developed a technology that uses applications on patient’s mobile devices to capture real-time patient reported outcomes.
“SpineMark’s Spine Protocol is a standardization of best management practices that results in transparency, data and compliance with global initiatives on quality patient care, ” explained Rogers, President and CEO of SpineMark. “Hospitals will not only meet, but also exceed current guidelines being developed by third party payors for designation of their network criteria. And, they will be able to objectively benchmark their data against literature, other centers and SpineMark’s network.”
“The Spine Protocol requires thorough accountability and continuous improvement thereby ensuring progressive care, ” said Millennium Environmental President, Paul Strange.
The company statement said the data collection system will compliment President Obama’s healthcare model taking a step closer to creating a global pricing structure as well as a disease based medical management model that assures accountability providing patients with the highest quality of care, by the right provider and facility at the right time.
SpineMark experienced a major shake-up within the last couple of years. This announcement was the first news from the company for a while.
React:
Discussion
This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?
Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.
We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.
Join the conversation
Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.